Filip Van den Bosch, MD, PhD

Head-of-Clinic and Associate Professor of Rheumatology
Ghent University Hospital
Ghent, Belgium

Rheumatologist

Presentation(s):

• 1434: Long-Term Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 148-Week Results from the KEEPsAKE 2 Trial

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.